Prolonged nicotine exposure reduces aversion to the drug in mice by altering nicotinic transmission in the interpeduncular nucleus
- Sorbonne Université, INSERM, CNRS, France
- ESPCI Paris, France
- Institut Pasteur, France
Abstract
Nicotine intake is likely to result from a balance between the rewarding and aversive properties of the drug, yet the individual differences in neural activity that control aversion to nicotine and their adaptation during the addiction process remain largely unknown. Using a two-bottle choice experiment, we observed considerable heterogeneity in nicotine-drinking profiles in isogenic adult male mice, with about half of the mice persisting in nicotine consumption even at high concentrations, whereas the other half stopped consuming. We found that nicotine intake was negatively correlated with nicotine-evoked currents in the interpeduncular nucleus (IPN), and that prolonged exposure to nicotine, by weakening this response, decreased aversion to the drug, and hence boosted consumption. Lastly, using knock-out mice and local gene re-expression, we identified b4-containing nicotinic acetylcholine receptors of IPN neurons as molecular and cellular correlates of nicotine aversion. Collectively, our results identify the IPN as a substrate for individual variabilities and adaptations in nicotine consumption.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files. Source data have been provided for all the figures.
Article and author information
Author details
Funding
Agence Nationale de la Recherche (ANR-21-CE16-0012 CHOLHAB)
- Alexandre Mourot
Labex Biopsy
- Claire Nguyen
Labex Memolife
- Joachim Jehl
Labex Memolife
- Alexandre Mourot
Agence Nationale de la Recherche (ANR-17-CE16-0016 SNP-NIC)
- Philippe Faure
Fondation pour la Recherche Médicale (FRM EQU201903007961)
- Philippe Faure
Institut National Du Cancer (TABAC-16-022)
- Philippe Faure
Institut National Du Cancer (TABAC-19-02)
- Philippe Faure
Institut National Du Cancer (SPA-21-002)
- Philippe Faure
Fondation de France (Prix Médisite)
- Alexandre Mourot
Fondation pour la Recherche Médicale (FDT201904008060)
- Sarah Mondoloni
Fondation pour la Recherche Médicale (FDT20170437427)
- Romain Durand-de Cuttoli
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: All experiments were performed in accordance with the recommendations for animal experiments issued by the European Commission directives 219/1990, 220/1990 and 2010/63, and approved by Sorbonne Université.
Reviewing Editor
- Lan Ma, Fudan University, China
Version history
- Preprint posted: December 17, 2021 (view preprint)
- Received: June 3, 2022
- Accepted: May 29, 2023
- Accepted Manuscript published: May 30, 2023 (version 1)
- Version of Record published: June 9, 2023 (version 2)
Copyright
© 2023, Mondoloni et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 548
- Page views
-
- 110
- Downloads
-
- 0
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Prolonged nicotine exposure reduces aversion to the drug in mice by altering nicotinic transmission in the interpeduncular nucleus
eLife 12:e80767.
https://doi.org/10.7554/eLife.80767
Further reading
-
- Chromosomes and Gene Expression
- Neuroscience
Mathys et al. conducted the first single-nucleus RNA-seq (snRNA-seq) study of Alzheimer’s disease (AD) (Mathys et al., 2019). With bulk RNA-seq, changes in gene expression across cell types can be lost, potentially masking the differentially expressed genes (DEGs) across different cell types. Through the use of single-cell techniques, the authors benefitted from increased resolution with the potential to uncover cell type-specific DEGs in AD for the first time. However, there were limitations in both their data processing and quality control and their differential expression analysis. Here, we correct these issues and use best-practice approaches to snRNA-seq differential expression, resulting in 549 times fewer DEGs at a false discovery rate of 0.05. Thus, this study highlights the impact of quality control and differential analysis methods on the discovery of disease-associated genes and aims to refocus the AD research field away from spuriously identified genes.
-
- Neuroscience
The strength of a fear memory significantly influences whether it drives adaptive or maladaptive behavior in the future. Yet, how mild and strong fear memories differ in underlying biology is not well understood. We hypothesized that this distinction may not be exclusively the result of changes within specific brain regions, but rather the outcome of collective changes in connectivity across multiple regions within the neural network. To test this, rats were fear conditioned in protocols of varying intensities to generate mild or strong memories. Neuronal activation driven by recall was measured using c-fos immunohistochemistry in 12 brain regions implicated in fear learning and memory. The interregional coordinated brain activity was computed and graph-based functional networks were generated to compare how mild and strong fear memories differ at the systems level. Our results show that mild fear recall is supported by a well-connected brain network with small-world properties in which the amygdala is well-positioned to be modulated by other regions. In contrast, this connectivity is disrupted in strong fear memories and the amygdala is isolated from other regions. These findings indicate that the neural systems underlying mild and strong fear memories differ, with implications for understanding and treating disorders of fear dysregulation.
